Search Results
May 27, 2026, 09:00 ET Chobani and U.S. Soccer Celebrate Top U.S. Men's National Team Players and All the People Who Helped Feed Their Dreams
were created from "biographical DNA" – meaningful photographs, documents, and found objects that reflect the players' unique paths."My work is rooted in concepts of DNA, building portraits from fragments that shape a person's life. I refer to it as 'biographical DNA', where I incorporate a wide range
More news about: Chobani, LLC
May 27, 2026, 09:00 ET Rennova® lidera agenda científica e projeta tendências para setor de estética em congresso científico em SP
dedicada a aulas exclusivas conduzidas por especialistas da marca e do mercado estético."Nossa participação como patrocinadores master reflete o DNA de uma marca genuinamente focada em ciência, tecnologia e inovação. Queremos que o profissional de saúde tenha o poder da escolha em suas
More news about: Rennova
May 27, 2026, 08:04 ET TransCode Therapeutics Initiates Phase 2a Clinical Trial with TTX-MC138 in Patients with ctDNA Positive Colorectal Cancer
initiation of its Phase 2a clinical trial. The study is to evaluate TransCode's lead therapeutic candidate, TTX‑MC138, in patients with circulating tumor DNA (ctDNA) positive colorectal cancer following curative‑intent therapy. The trial is being conducted in collaboration with Quantum Leap Healthcare Collaborative
More news about: TransCode Therapeutics, Inc.
May 27, 2026, 08:00 ET Minaris Expands Rapid Mycoplasma Detection Services with bioMérieux's BIOFIRE® Platform to Reduce Turnaround Time for Release and In-Process Testing
qualifications (PSQ) under realistic contamination conditions, an approach that is more representative of true contamination scenarios than controls based on DNA alone, as it validates the entire detection workflow end-to-end.With this expanded capability, Minaris Advanced Testing now offers three methods
More news about: Minaris Advanced Therapies, LLC
May 27, 2026, 07:36 ET American Cancer Society Updates Colorectal Cancer Screening Guideline: Major Changes Emphasize Blood-Based and At-Home Stool Testing
generation-ng-mt-sDNA test (brand name Cologuard), which is an updated version of an already-recommended at-home mt-sDNA test analyzing stool samples for specific DNA markers and hemoglobin.A mt-sRNA test (brand name ColoSense) is a new at-home multi-target test that analyzes stool samples for specific RNA
More news about: American Cancer Society
May 27, 2026, 07:01 ET ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening
screening options for adults aged 45 or older who are at average risk for the disease. The Cologuard test revolutionized CRC screening by detecting specific DNA markers and blood in stool associated with cancer and precancer, allowing patients to complete the collection kit at home without special preparation
More news about: Abbott
May 27, 2026, 07:00 ET Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
completion of PEG-IFNα + elebsiran treatment. Functional cure rates at the end of ENSURE study, defined as sustained HBsAg loss with undetectable HBV DNA for at least 24 weeks after stopping all treatment, including NAs, are presented. Final results demonstrated that the HBsAg loss benefit observed in
More news about: Brii Biosciences Limited
May 27, 2026, 07:00 ET BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
life-changing therapies in oncology and rare diseases. The Company's lead development asset is GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other solid tumors, for which a Phase 1/2a clinical trial was initiated in the first quarter of 2026. GLIX1 is being
More news about: BioLineRx Ltd.
May 27, 2026, 06:02 ET Mphasis Launches Mphasis Tria™, a First-of-its-Kind Enterprise Agency Platform; Governed Front2Back™,Accelerates Mphasis' Evolution into a Platform-Led AI Enterprise
governed reasoning, simulation, and enterprise-scale decision intelligence.About Mphasis At Mphasis, engineering has been in our DNA since inception.Mphasis is an AI-led, platform-driven company with human-in-the-loop intelligence, helping global enterprises modernize, infuse
More news about: Mphasis
May 27, 2026, 03:33 ET Only 65 percent of employers taking action on women's health at work but progress remains fragmented, reveals Kearney
health challenges that affect their experience at work every single day."The companies making real progress are embedding women's health into the DNA of workforce strategy, building stronger cultures, retaining critical talent, and creating healthier, higher-performing workforces.About Kearney
More news about: Kearney
May 26, 2026, 13:53 ET ATLANTIS PARADISE ISLAND, BAHAMAS COMEMORA O MÊS DO OCEANO MUNDIAL E DUAS DÉCADAS DE IMPACTO NA CONSERVAÇÃO MARINHA
restauração de recifes de corais e contribuíram para a proteção de mais de 1,4 milhão de acres de habitat marinho."A conservação marinha está em nosso DNA e o Mês Mundial dos Oceanos é o momento perfeito para comemorar com os membros de nossa equipe e convidados", disse Audrey Oswell, presidente e diretora
More news about: Atlantis, Paradise Island
May 26, 2026, 12:33 ET Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
Ginkgo Bioworks (NYSE: DNA) today announced that its Datapoints offering is launching
More news about: Inductive Bio, Inc.
May 26, 2026, 11:46 ET ATLANTIS PARADISE ISLAND, THE BAHAMAS COMMEMORATES WORLD OCEAN MONTH AND TWO DECADES OF MARINE CONSERVATION IMPACT
reef research and restoration, and contributed to the protection of more than 1.4 million acres of marine habitat."Marine conservation is in our DNA and World Ocean Month is the perfect time to celebrate with our team members and guests," said Audrey Oswell, President and Managing Director of Atlantis
More news about: Atlantis, Paradise Island
May 26, 2026, 09:00 ET Adela Highlights Progress on Multi-Cancer Early Detection Study at the 2026 ASCO Annual Meeting
degrade limited blood-derived DNA. This allows us to access a broad, biologically informative view of cancer-associated methylation from a blood draw, with the potential to improve sensitivity, in particular for early stage and low-shedding cancers, when tumor-derived DNA is present at very low levels
More news about: Adela
May 26, 2026, 09:00 ET B Corp Certified IKOO GLASS Pioneers Better Global Kitchen Lifestyles with Top 7 iF Design Ranking
Kitchenware. This leap reflects the team's precise grasp of market trends and deep insights into user pain points. Today, innovative design is the core DNA of IKOO's global client services. Delivering over 100 innovative solutions annually, the R&D team directly helps clients shorten development cycles,
More news about: IKOO GLASS
May 26, 2026, 09:00 ET Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026
2026, from 1:30 p.m. to 4:30 p.m. CT Evaluation of whole-exome & whole-genome sequencing tumor-informed circulating tumor DNA MRD assays in patients with early triple-negative breast cancer (TNBC) receiving neoadjuvant chemotherapy (NAC) with or without olaparib: A prospective
More news about: Abbott
May 26, 2026, 09:00 ET Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
May 26, 2026, 07:25 ET Tata Elxsi Launches ViTel™, a Material Intelligence Solution for Med-Tech Powered by Viridium AI
readiness." Niraj Deo, Chief Executive Officer, Viridium AI: "Viridium AI was built to help manufacturers understand the material DNA of their products. In Med-Tech, that intelligence creates a strategic foundation for the manufacturer. Once product and material knowledge are digitized,
More news about: Tata Elxsi
May 25, 2026, 10:01 ET CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
Antiviral Drugs Market by Product Type (DNA Polymerase Inhibitors, Others), Brand Type (Branded, Generics), Application (HIV, Hepatitis, Herpes, Influenza, Others), and Regional Analysis for 2026
More news about: Persistence Market Research Pvt. Ltd.
May 23, 2026, 07:01 ET 第四屆「中銀香港科技創新獎」頒獎典禮圓滿舉行 五大領域科研成果亮相 彰顯香港創科轉化實力
本屆五大領域獲獎者及團隊的科研成果兼具國際前沿性與應用價值，於核心技術突破及成果轉化方面作出傑出貢獻。本屆獲獎者/團隊分別為：「人工智能及機器人」領域林達華教授，表彰他在計算機視覺與多模態智能領域進行系統性創新；「生命健康」領域陳君賜教授，表彰他在血漿 DNA 非侵入性診斷技術研發方面的卓越貢獻；「先進製造」領域余長源教授，表彰他在光子信息器件及系統研發與應用領域的突破；「金融科技」領域郭彥麟先生、葉沛賢女士及章昱先生，表彰他們在數碼資產保險及生成人工智能安全領域的創新成果；以及「新材料新能源」領域盧怡君教授，表彰她在水系電池領域的開創性貢獻。
More news about: 香港科技創新聯盟
May 22, 2026, 18:05 ET Spoločnosť Shanghai Electric si pripomína Medzinárodný deň biologickej diverzity lokálnymi ekologickými postupmi
ŠANGHAJ, 23. mája 2026 /PRNewswire/ -- Pri príležitosti Medzinárodného dňa biologickej diverzity 22. mája spoločnosť Shanghai Electric (SEHK: 02727, SSE: 601727) zdôrazňuje lokálne ekologické postupy vo svojich továrňach a projektových
More news about: Shanghai Electric
May 22, 2026, 15:15 ET Dia Internacional da Biodiversidade: monitoramento em larga escala impulsiona conservação em áreas privadas
herpetofauna sem que um especialista precise estar presente no campo, otimizando tempo e ampliando a cobertura geográfica. No ambiente aquático, o uso de eDNA (DNA ambiental) representa um avanço relevante, pois permite identificar espécies a partir de fragmentos de material genético presentes na água, viabilizando
More news about: Ecofuturo
May 22, 2026, 08:49 ET Free People to Collaborate with Volkswagen
ahead. Collaborating with Free People felt like a natural fit; both brands carry a spirit of freedom and wanderlust that's been part of Volkswagen's DNA for decades. We're thrilled to bring that feeling to life this summer in a way that's fresh, fun, and deeply authentic to who we are," said Rachael Zaluzec,
More news about: Free People
May 22, 2026, 08:30 ET Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence
and Genetics. Date/Time: Sunday, May 31, 2026 — 10:51 AM–10:57 AM CDT. Location: S403.Posters with Merit Award Mitochondrial DNA (mtDNA) expression as used to define metabolic and immune states in colorectal cancer (CRC). (Abstract 2647) Session: Developmental Therapeutics—Immunotherapy.
More news about: Caris Life Sciences
May 22, 2026, 08:00 ET Parker Institute for Cancer Immunotherapy Brings the Power of Its Integrated Network to ASCO 2026
cancer (Abstract TPW8132, lead author).Urothelial ctDNA Dynamics (Sangeeta Goswami, MD, PhD — MD Anderson): Circulating tumor DNA dynamics as an early biomarker of response to enfortumab vedotin plus pembrolizumab in advanced urothelial carcinoma (Abstract 4582).Macrophage
More news about: Parker Institute for Cancer Immunotherapy